ArticleFrontiers in oncology2025

Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma.

Hongyu Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.